Since radioresistance is a major cause that leads to the poor outcomes of NPC patients, we analyzed the ability of RKIP to predict disease free survival (DFS) and overall survival (OS) of the patients. This evidence concerns the gene PEBP1 and nasopharyngeal carcinoma.